Evaluation of sitaxentan (Thelin®) toxicity in juvenile rats and regulatory interactions during the development of a European Medicines Agency pediatric investigation plan

► Sitaxentan toxicity was assessed in juvenile rats. ► Using multiple endpoints, there were no safety concerns specific to juvenile rats. ► Changes identified related to expected pharmacology. ► Regulatory interactions supported study design and justification.